Bouché O - Search Results

1

Digestive System Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.

de Mestier L, Cros J, Neuzillet C, Hentic O, Egal A, Muller N, Bouché O, Cadiot G, Ruszniewski P, Couvelard A, Hammel P. de Mestier L, et al. Among authors: bouche o. Neuroendocrinology. 2017;105(4):412-425. doi: 10.1159/000475527. Epub 2017 Aug 12. Neuroendocrinology. 2017. PMID: 28803232 Review.

2

Colonic flat neoplasia: frequency and concordance between endoscopic appearance and histological diagnosis in a French prospective series.

Diebold MD, Samalin E, Merle C, Bouché O, Higuero T, Jolly D, Ramaholimihaso F, Renard P, Yaziji N, Thiéfin G, Cadiot G. Diebold MD, et al. Among authors: bouche o. Am J Gastroenterol. 2004 Sep;99(9):1795-800. doi: 10.1111/j.1572-0241.2004.40236.x. Am J Gastroenterol. 2004. PMID: 15330921 No abstract available.

3

Risk factors and long-term course of thyroid dysfunction during antiviral treatments in 221 patients with chronic hepatitis C.

Moncoucy X, Leymarie F, Delemer B, Lévy S, Bernard-Chabert B, Bouché O, Jolly D, Diebold MD, Cadiot G, Thiéfin G. Moncoucy X, et al. Among authors: bouche o. Gastroenterol Clin Biol. 2005 Apr;29(4):339-45. doi: 10.1016/s0399-8320(05)80778-x. Gastroenterol Clin Biol. 2005. PMID: 15864192 Free article.

4

Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey.

Bensoussan M, Jovenin N, Garcia B, Vandromme L, Jolly D, Bouché O, Thiéfin G, Cadiot G. Bensoussan M, et al. Among authors: bouche o. Gastroenterol Clin Biol. 2006 Jan;30(1):14-23. doi: 10.1016/s0399-8320(06)73072-x. Gastroenterol Clin Biol. 2006. PMID: 16514377 Free article.

5

Is palliative laparoscopic hyperthermic intraperitoneal chemotherapy effective in patients with malignant hemorrhagic ascites?

de Mestier L, Volet J, Scaglia E, Msika S, Kianmanesh R, Bouché O. de Mestier L, et al. Among authors: bouche o. Case Rep Gastroenterol. 2012 Jan;6(1):166-70. doi: 10.1159/000338070. Epub 2012 Apr 3. Case Rep Gastroenterol. 2012. PMID: 22679405 Free PMC article.

6

Pancreas cancer-associated polymyositis of the legs regressing after cephalic duodenopancreatectomy: case report and review of the literature.

Amroun KL, De Mestier L, Deguelte-Lardiere S, Diebold MD, Bouché O, Kianmanesh R. Amroun KL, et al. Among authors: bouche o. JOP. 2012 Nov 10;13(6):674-6. doi: 10.6092/1590-8577/1183. JOP. 2012. PMID: 23183398 Free article. Review.

7

Prognostic factors in patients with non resectable metastatic colorectal cancer in the era of targeted biotherapies: relevance of Köhne's risk classification.

Desot E, de Mestier L, Volet J, Delmas C, Garcia B, Geoffroy P, Abdelli N, Baule M, Dubroeucq O, Marquis E, Bouché O. Desot E, et al. Among authors: bouche o. Dig Liver Dis. 2013 Apr;45(4):330-5. doi: 10.1016/j.dld.2012.10.016. Epub 2012 Nov 30. Dig Liver Dis. 2013. PMID: 23201298

8

Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.

de Mestier L, Manceau G, Neuzillet C, Bachet JB, Spano JP, Kianmanesh R, Vaillant JC, Bouché O, Hannoun L, Karoui M. de Mestier L, et al. Among authors: bouche o. World J Gastrointest Oncol. 2014 Jun 15;6(6):156-69. doi: 10.4251/wjgo.v6.i6.156. World J Gastrointest Oncol. 2014. PMID: 24936226 Free PMC article. Review.

9

Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Fédération Francophone de Cancérologie Digestive, Fédération Nationale des Centres de Lutte Contre le Cancer, and Groupe Coopérateur Multidisciplinaire en Oncologie) study.

Guimbaud R, Louvet C, Ries P, Ychou M, Maillard E, André T, Gornet JM, Aparicio T, Nguyen S, Azzedine A, Etienne PL, Boucher E, Rebischung C, Hammel P, Rougier P, Bedenne L, Bouché O. Guimbaud R, et al. Among authors: bouche o. J Clin Oncol. 2014 Nov 1;32(31):3520-6. doi: 10.1200/JCO.2013.54.1011. Epub 2014 Oct 6. J Clin Oncol. 2014. PMID: 25287828 Clinical Trial.

10

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial.

Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P, Borbath I, Bouché O, Shannon J, André T, Mineur L, Chibaudel B, Bonnetain F, Louvet C; LAP07 Trial Group. Hammel P, et al. Among authors: bouche o. JAMA. 2016 May 3;315(17):1844-53. doi: 10.1001/jama.2016.4324. JAMA. 2016. PMID: 27139057 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

411 results

Search Page

Filters